Literature DB >> 16004969

Chemokines derived from soluble fusion proteins expressed in Escherichia coli are biologically active.

Giovanni Magistrelli1, Franck Gueneau, Machadiya Muslmani, Ulla Ravn, Marie Kosco-Vilbois, Nicolas Fischer.   

Abstract

Chemokines are a class of low molecular weight proteins that are involved in leukocytes trafficking. Due to their involvement in recruiting immune cells to sites of inflammation, chemokines, and chemokine receptors have become an attractive class of therapeutic targets. However, when expressed in Escherichia coli chemokines are poorly soluble and accumulate in inclusion bodies. Several purification methods have been described but involve time-consuming refolding, buffer exchange, and purification steps that complicate expression of these proteins. Here, we describe a simple and reliable method to express chemokines as fusions to the protein NusA. The fusion proteins were largely found in the soluble fraction and could be readily purified in a single step. Proteolytic cleavage was used to obtain soluble recombinant chemokines that were found to be very active in a novel in vitro chemotaxis assays. This method could be applied to several alpha and beta human chemokines, suggesting that it is generally applicable to this class of proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004969     DOI: 10.1016/j.bbrc.2005.06.091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein.

Authors:  Thu Trang Thi Vu; Bon-Kyung Koo; Jung-A Song; Seon-Ha Chong; Cho Rong Park; Minh Tan Nguyen; Boram Jeong; Han-Bong Ryu; Jae Young Seong; Yeon Jin Jang; Robert Charles Robinson; Han Choe
Journal:  Mol Biol Rep       Date:  2014-11-13       Impact factor: 2.316

2.  Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.

Authors:  Pauline Bonvin; Franck Gueneau; Vanessa Buatois; Maud Charreton-Galby; Stanley Lasch; Marie Messmer; Urs Christen; Andrew D Luster; Zoë Johnson; Walter Ferlin; Marie Kosco-Vilbois; Amanda Proudfoot; Nicolas Fischer
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

3.  Identification of the pharmacophore of the CC chemokine-binding proteins Evasin-1 and -4 using phage display.

Authors:  Pauline Bonvin; Steven M Dunn; François Rousseau; Douglas P Dyer; Jeffrey Shaw; Christine A Power; Tracy M Handel; Amanda E I Proudfoot
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

4.  Dual specificity of anti-CXCL10-CXCL9 antibodies is governed by structural mimicry.

Authors:  Séverine Fagète; François Rousseau; Giovanni Magistrelli; Franck Gueneau; Ulla Ravn; Marie H Kosco-Vilbois; Nicolas Fischer
Journal:  J Biol Chem       Date:  2011-10-31       Impact factor: 5.157

5.  The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants.

Authors:  Massimiliano Secchi; Qiang Xu; Paolo Lusso; Luca Vangelista
Journal:  Protein Expr Purif       Date:  2009-06-30       Impact factor: 1.650

6.  Specificity tuning of antibody fragments to neutralize two human chemokines with a single agent.

Authors:  Séverine Fagète; Ulla Ravn; Franck Gueneau; Giovanni Magistrelli; Marie H Kosco-Vilbois; Nicolas Fischer
Journal:  MAbs       Date:  2009 May-Jun       Impact factor: 5.857

7.  Functional expression of CCL8 and its interaction with chemokine receptor CCR3.

Authors:  Baosheng Ge; Jiqiang Li; Zhijin Wei; Tingting Sun; Yanzhuo Song; Naseer Ullah Khan
Journal:  BMC Immunol       Date:  2017-12-28       Impact factor: 3.615

8.  3D profile-based approach to proteome-wide discovery of novel human chemokines.

Authors:  Aurelie Tomczak; Jana Sontheimer; David Drechsel; Rainer Hausdorf; Marc Gentzel; Andrej Shevchenko; Stefanie Eichler; Karim Fahmy; Frank Buchholz; M Teresa Pisabarro
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

9.  Soluble prokaryotic overexpression and purification of bioactive human granulocyte colony-stimulating factor by maltose binding protein and protein disulfide isomerase.

Authors:  Bich Hang Do; Han-Bong Ryu; Phuong Hoang; Bon-Kyung Koo; Han Choe
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.